304
Participants
Start Date
June 30, 2004
Primary Completion Date
December 31, 2010
Study Completion Date
December 31, 2010
Etoposide
Doxorubicin
Cisplatin
Streptozotocin
Mitotane
Vrije Universiteit Medisch Centrum, Amsterdam
University of Graz, Graz
University Hospital Groningen; Dept. of Internal Medine, Groningen
University of Turin, Dept of Internal Medicine, Orbassano
Hospital de Marseille la timone, Marseille
Hospital Bordeaux haut leveque, Pessac
Otto-von-Guericke University; Dept. of Endocrinology, Magdeburg
University of Duesseldorf, Dept. of Endocrrinology, Düsseldorf
University of Michigan, Department of Internal Medicine, Ann Arbor
Cochin Hospital, Paris
University of Munich, Dept. of Internal Medicine (Innenstadt), Munich
Institut Gustave Roussy, Villejuif
University of Wuerzburg - Dept. of Medicine, Würzburg
National Cancer Institute - Center for Cancer Research, Bethesda
Clinique Marc Linquette, Lille
Centre Leon Berard, Lyon
Charité-University, Dept. of Endocrinology; Campus Benjamin Franklin, Berlin
Charité-Universitätsmedizin Berlin - Campus Mitte, Berlin
Dept. of Medicine III, Dresden
Zentrum für Innere Medizin - Endokrinologie des Universitätsklinikum Essen, Essen
Endokrinologie Medizinische Hochschule Hannover, Hanover
Dept of Medicine I, Mainz
Clinica Endocrinologica, Università di Padova, Azienda Ospedaliera di Padova, Padua
Leiden University Medical Center, Leiden
Department of Oncology, Sahlgrenska University Hospital, Gothenburg
Department of Oncology, Linköping University Hospital, Linköping
Department of Medicine, The Jubileum Institute, Lund University, Lund
Dept of Surgery, Karolinska Hospital, Stockholm, Stockholm
Royal Adelaide Hospital, Adelaide
Academisch Medisch Centrum; Dept. of Endocrinology, Amsterdam
Maxima Medisch Centrum; Dept. of Internal Medicine, Eindhoven
Uppsala University Hospital - Dept of Medical Sciences, Uppsala
German Federal Ministry of Education and Research
OTHER_GOV
National Cancer Institute (NCI)
NIH
Collaborative Group for Adrenocortical Carcinoma Treatment
OTHER